Inhibition of Yin Yang 1-Dependent Repressor Activity of DR5 Transcription and Expression by the Novel Proteasome Inhibitor NPI-0052 Contributes to its TRAIL-Enhanced Apoptosis in Cancer Cells-Reference-Cited by-同舟云学术

Inhibition of Yin Yang 1-Dependent Repressor Activity of DR5 Transcription and Expression by the Novel Proteasome Inhibitor NPI-0052 Contributes to its TRAIL-Enhanced Apoptosis in Cancer Cells

Published:2008-04-18 Issue:9 Volume:180 Page:6199-6210
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Baritaki Stavroula,Suzuki Eriko,Umezawa Kazuo,Spandidos Demetrios A.,Berenson James,Daniels Tracy R.,Penichet Manuel L.,Jazirehi Ali R.,Palladino Michael,Bonavida Benjamin

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference59 articles.

1. Nuclear factor-κB

2. The development of proteasome inhibitors as anticancer drugs

3. Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB

4. A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implications;Exploration of Targeted Anti-tumor Therapy;2023-04-20

2. Marine-derived pipeline anticancer natural products: a review of their pharmacotherapeutic potential and molecular mechanisms;Future Journal of Pharmaceutical Sciences;2021-10-15

3. Marine Power on Cancer: Drugs, Lead Compounds, and Mechanisms;Marine Drugs;2021-08-27

4. Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy;Genes & Immunity;2020-08-25

5. Therapeutic targeting of SNAIL, RKIP, and YY1 in tumor metastasis and drug resistance;Prognostic and Therapeutic Applications of RKIP in Cancer;2020